These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24145865)

  • 21. Health care costs associated with Australian tertiary inflammatory bowel disease care.
    Jackson B; Con D; Ma R; Gorelik A; Liew D; De Cruz P
    Scand J Gastroenterol; 2017 Aug; 52(8):851-856. PubMed ID: 28509590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose Escalation and Healthcare Resource Use among Ulcerative Colitis Patients Treated with Adalimumab in English Hospitals: An Analysis of Real-World Data.
    Black CM; Yu E; McCann E; Kachroo S
    PLoS One; 2016; 11(2):e0149692. PubMed ID: 26919745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral tacrolimus as maintenance therapy for refractory ulcerative colitis--an analysis of outcomes in two London tertiary centres.
    Landy J; Wahed M; Peake ST; Hussein M; Ng SC; Lindsay JO; Hart AL
    J Crohns Colitis; 2013 Dec; 7(11):e516-21. PubMed ID: 23623737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Granulo-monocyto apheresis is more effective in mild ulcerative colitis than in moderate to severe disease.
    De Cassan C; Savarino E; Marson P; Tison T; Hatem G; Sturniolo GC; D'Incà R
    World J Gastroenterol; 2014 Dec; 20(45):17155-62. PubMed ID: 25493030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma.
    Lee PP; Walt JG; Doyle JJ; Kotak SV; Evans SJ; Budenz DL; Chen PP; Coleman AL; Feldman RM; Jampel HD; Katz LJ; Mills RP; Myers JS; Noecker RJ; Piltz-Seymour JR; Ritch RR; Schacknow PN; Serle JB; Trick GL
    Arch Ophthalmol; 2006 Jan; 124(1):12-9. PubMed ID: 16401779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study.
    van der Valk ME; Mangen MJ; Leenders M; Dijkstra G; van Bodegraven AA; Fidder HH; de Jong DJ; Pierik M; van der Woude CJ; Romberg-Camps MJ; Clemens CH; Jansen JM; Mahmmod N; van de Meeberg PC; van der Meulen-de Jong AE; Ponsioen CY; Bolwerk CJ; Vermeijden JR; Siersema PD; van Oijen MG; Oldenburg B;
    Gut; 2014 Jan; 63(1):72-9. PubMed ID: 23135759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of infliximab use in ulcerative colitis.
    Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
    Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of golimumab for the treatment of patients with moderate-to-severe ulcerative colitis in Quebec using a patient level state transition microsimulation.
    Stern S; Ward AJ; Saint-Laurent Thibault C; Camacho F; Rahme E; Naessens D; Aumais G; Bernard EJ; Bourdages R; Cohen A; Pare P; Dyrda P
    J Med Econ; 2018 Jan; 21(1):27-37. PubMed ID: 28830258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct costs of glaucoma and severity of the disease: a multinational long term study of resource utilisation in Europe.
    Traverso CE; Walt JG; Kelly SP; Hommer AH; Bron AM; Denis P; Nordmann JP; Renard JP; Bayer A; Grehn F; Pfeiffer N; Cedrone C; Gandolfi S; Orzalesi N; Nucci C; Rossetti L; Azuara-Blanco A; Bagnis A; Hitchings R; Salmon JF; Bricola G; Buchholz PM; Kotak SV; Katz LM; Siegartel LR; Doyle JJ
    Br J Ophthalmol; 2005 Oct; 89(10):1245-9. PubMed ID: 16170109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost of Ulcerative Colitis in Quebec, Canada: A Retrospective Cohort Study.
    Dan A; Boutros M; Nedjar H; Kopylov U; Afif W; Khalil MA; Rahme E
    Inflamm Bowel Dis; 2017 Aug; 23(8):1262-1271. PubMed ID: 28691933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
    Pelletier EM; Shim B; Goodman S; Amonkar MM
    Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The direct and indirect cost burden of Crohn's disease and ulcerative colitis.
    Gibson TB; Ng E; Ozminkowski RJ; Wang S; Burton WN; Goetzel RZ; Maclean R
    J Occup Environ Med; 2008 Nov; 50(11):1261-72. PubMed ID: 19001952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resource utilization before and during infliximab therapy in patients with inflammatory bowel disease.
    Waters HC; Vanderpoel JE; Nejadnik B; McKenzie RS; Lunacsek OE; Lennert BJ; Goff J; Augustyn DH
    J Med Econ; 2012; 15(1):45-52. PubMed ID: 22023068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study).
    Johnston K; Levy AR; Lorigan P; Maio M; Lebbe C; Middleton M; Testori A; Bédane C; Konto C; Dueymes A; Sbarigia U; van Baardewijk M
    Eur J Cancer; 2012 Sep; 48(14):2175-82. PubMed ID: 22480965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patients' perceptions, attitudes, and experiences about the management of mild-to-moderate ulcerative colitis.
    Casellas F; Vicens DG; Menéndez SR; Oliver NA
    J Crohns Colitis; 2014 Sep; 8(9):1097-107. PubMed ID: 24613279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Economic analysis of endovascular repair versus surveillance for patients with small abdominal aortic aneurysms.
    Eisenstein EL; Davidson-Ray L; Edwards R; Anstrom KJ; Ouriel K
    J Vasc Surg; 2013 Aug; 58(2):302-10. PubMed ID: 23562339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Costs of health services utilization of people with fetal alcohol spectrum disorder by sex and age group in Alberta, Canada.
    Thanh NX; Jonsson E
    J Popul Ther Clin Pharmacol; 2014; 21(3):e421-30. PubMed ID: 25658807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost of multiple sclerosis in the Czech Republic: the COMS study.
    Blahova Dusankova J; Kalincik T; Dolezal T; Kobelt G; Havrdova E
    Mult Scler; 2012 May; 18(5):662-8. PubMed ID: 21965424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.
    Cassinotti A; Actis GC; Duca P; Massari A; Colombo E; Gai E; Annese V; D'Albasio G; Manes G; Travis S; Porro GB; Ardizzone S
    Am J Gastroenterol; 2009 Nov; 104(11):2760-7. PubMed ID: 19623172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucosal Healing in Ulcerative Colitis--When Zero is Better.
    Boal Carvalho P; Dias de Castro F; Rosa B; Moreira MJ; Cotter J
    J Crohns Colitis; 2016 Jan; 10(1):20-5. PubMed ID: 26438714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.